Cognito Therapeutics Funding: $93M Raised, Series B (2023)
Cognito Therapeutics is based in Cambridge. It has raised $93M in total funding. Latest round: Series B.
Cognito Therapeutics funding overview
Cognito Therapeutics is based in Cambridge. Cognito Therapeutics has raised $93M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2023. The round record for Cognito Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include FoundersX Ventures, Alzheimer's Drug Discovery Foundation, Starbloom Capital, IAG Capital, WS Investment Company, Morningside. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Cognito Therapeutics funding
How much has Cognito Therapeutics raised?
Cognito Therapeutics has raised $93M in total disclosed funding across the rounds on record.
Who has invested in Cognito Therapeutics?
FoundersX Ventures, Alzheimer's Drug Discovery Foundation, Starbloom Capital, IAG Capital, WS Investment Company, Morningside are named among the investors backing Cognito Therapeutics.
What was the latest Cognito Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2023.
Where is Cognito Therapeutics based?
Cognito Therapeutics is based in Cambridge.
When did Cognito Therapeutics last raise?
The last disclosed Cognito Therapeutics round closed in January 2023 at Series B.
Cognito Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
